There is also increasing evidence in their medium- to long-term benefits to metabolic outcomes in those with obesity, due to improvements in weight and glycemia, as well as direct action of GLP-1 on multiple organ systems. Here, GCG is linked to obesity due to melanocortin 4 receptor deficiency.